In NSCLC, RET fusion presents mainly in adenocarcinomas of non-smoker patients, and the partner that is most frequently associated in this setting is KIF5B. In lung adenocarcinoma, the presence of calcifications in the form of psammoma bodies could be indicative of the possibility of finding this alteration [75]. This evidence concerns the gene RET and non-small cell lung carcinoma.